Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Bone Density × Tamoxifen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 133 Neoplasm Metastasis 9 Carcinoma, Intraductal, Noninfiltrating 9 Breast Neoplasms, Male 9 Breast Carcinoma In Situ 7 Neoplasms 5 Ovarian Neoplasms 3 Inflammatory Breast Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Ductal, Breast 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Hot Flashes 2 Gliosarcoma 2 Glioma 2 Glioblastoma 2 Fibroadenoma 2 Fallopian Tube Neoplasms 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Brain Neoplasms 2 Sleep Wake Disorders 1 Sarcoma 1 Risk Reduction Behavior 1 Recurrence 1 Quality of Life 1 Primary Breast Cancer 1 Precancerous Conditions 1 Patient Acceptance of Health Care 1

Interventions

Tamoxifen 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00784940 2009-04-27

ATAC - Bone Density Sub-Protocol

AstraZeneca

Phase 3 Completed

Bone Density

Data powered by HemOnc (CC BY 4.0) Colophon ⚡